Skip to main content
Equibles

UBS Group AG

Position in TARS — Tarsus Pharmaceuticals, Inc.

CIK 1610520 ZURICH, V8
Back to TARS Full portfolio

Position in TARS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$4,627,851
-$1,133,146 QoQ
Shares Held
73,528
-10.5% QoQ
Ownership
0.168%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#66
of 256 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority Sole 96% Shared 0% None 4%

Common Shares in TARS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,801 across 560 Biotechnology names. TARS ranks #152 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in TARS

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,627,851 73,528
2026-03-31 $5,760,997 82,124
2025-12-31 $5,477,689 66,899
2025-09-30 $7,046,139 118,562
2025-06-30 $1,154,777 28,506
2025-03-31 $4,761,330 92,687
2024-12-31 $3,394,567 61,307
2024-09-30 $2,279,802 69,316
2024-06-30 $760,306 27,973
2024-03-31 $1,393,659 38,340
2023-12-31 $617,483 30,493
2023-09-30 $337,647 19,001
2023-06-30 $315,538 17,462
2023-03-31 $101,276 8,057
2022-12-31 $100,538 6,858
2022-09-30 $11,984 700
2022-06-30 $10,220 700
2022-03-31 $71,080 4,226
2021-12-31 $69,390 3,084
2021-09-30 $10,775 500
2021-03-31 $80,446 2,496
2020-12-31 $54,762 1,325